JP2021533806A5 - - Google Patents
Info
- Publication number
- JP2021533806A5 JP2021533806A5 JP2021510030A JP2021510030A JP2021533806A5 JP 2021533806 A5 JP2021533806 A5 JP 2021533806A5 JP 2021510030 A JP2021510030 A JP 2021510030A JP 2021510030 A JP2021510030 A JP 2021510030A JP 2021533806 A5 JP2021533806 A5 JP 2021533806A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- antigen
- acid sequence
- binding
- Prior art date
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023172194A JP7541167B2 (ja) | 2018-08-23 | 2023-10-03 | 抗ｆｃイプシロン－ｒ１アルファ（ｆｃｅｒ１ａ）抗体、ｆｃｅｒ１ａおよびｃｄ３に結合する二重特異性抗原結合分子、ならびにそれらの使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862721921P | 2018-08-23 | 2018-08-23 | |
| US62/721,921 | 2018-08-23 | ||
| PCT/US2019/047601 WO2020041537A1 (en) | 2018-08-23 | 2019-08-22 | Anti-fc epsilon-r1 alpha (fcer1a) antibodies, bispecific antigen-binding molecules that bind fcer1a and cd3, and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023172194A Division JP7541167B2 (ja) | 2018-08-23 | 2023-10-03 | 抗ｆｃイプシロン－ｒ１アルファ（ｆｃｅｒ１ａ）抗体、ｆｃｅｒ１ａおよびｃｄ３に結合する二重特異性抗原結合分子、ならびにそれらの使用 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021533806A JP2021533806A (ja) | 2021-12-09 |
| JP2021533806A5 true JP2021533806A5 (https=) | 2022-08-04 |
| JPWO2020041537A5 JPWO2020041537A5 (https=) | 2022-08-04 |
| JP7402223B2 JP7402223B2 (ja) | 2023-12-20 |
Family
ID=67876086
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021510030A Active JP7402223B2 (ja) | 2018-08-23 | 2019-08-22 | 抗ｆｃイプシロン－ｒ１アルファ（ｆｃｅｒ１ａ）抗体、ｆｃｅｒ１ａおよびｃｄ３に結合する二重特異性抗原結合分子、ならびにそれらの使用 |
| JP2023172194A Active JP7541167B2 (ja) | 2018-08-23 | 2023-10-03 | 抗ｆｃイプシロン－ｒ１アルファ（ｆｃｅｒ１ａ）抗体、ｆｃｅｒ１ａおよびｃｄ３に結合する二重特異性抗原結合分子、ならびにそれらの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023172194A Active JP7541167B2 (ja) | 2018-08-23 | 2023-10-03 | 抗ｆｃイプシロン－ｒ１アルファ（ｆｃｅｒ１ａ）抗体、ｆｃｅｒ１ａおよびｃｄ３に結合する二重特異性抗原結合分子、ならびにそれらの使用 |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US11578127B2 (https=) |
| EP (1) | EP3840841A1 (https=) |
| JP (2) | JP7402223B2 (https=) |
| KR (1) | KR20210049863A (https=) |
| CN (1) | CN112888482B (https=) |
| AU (1) | AU2019325565B2 (https=) |
| BR (1) | BR112021003023A2 (https=) |
| CA (1) | CA3109513A1 (https=) |
| CL (2) | CL2021000437A1 (https=) |
| CO (1) | CO2021003608A2 (https=) |
| EA (1) | EA202190601A1 (https=) |
| IL (1) | IL280745B1 (https=) |
| MX (1) | MX2021002165A (https=) |
| MY (1) | MY204368A (https=) |
| PH (1) | PH12021550322A1 (https=) |
| SG (1) | SG11202101608XA (https=) |
| WO (1) | WO2020041537A1 (https=) |
| ZA (1) | ZA202100919B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3840841A1 (en) | 2018-08-23 | 2021-06-30 | Regeneron Pharmaceuticals, Inc. | Anti-fc epsilon-r1 alpha (fcer1a) antibodies, bispecific antigen-binding molecules that bind fcer1a and cd3, and uses thereof |
| WO2021159128A2 (en) * | 2020-01-31 | 2021-08-12 | Randy Leiman Allen | Methods and kit for detection of analytes |
| WO2025149667A1 (en) | 2024-01-12 | 2025-07-17 | Pheon Therapeutics Ltd | Antibody drug conjugates and uses thereof |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| EP1400536A1 (en) | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| WO2006028956A2 (en) * | 2004-09-02 | 2006-03-16 | Genentech, Inc. | Anti-fc-gamma riib receptor antibody and uses therefor |
| ES2398076T3 (es) | 2006-06-02 | 2013-03-13 | Regeneron Pharmaceuticals, Inc. | Anticuerpos de alta afinidad contra el receptor de IL-6 humano |
| JP5816170B2 (ja) | 2009-06-26 | 2015-11-18 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 天然の免疫グロブリン形式を有する容易に単離される二重特異性抗体 |
| SI2501817T2 (sl) | 2010-02-08 | 2021-09-30 | Regeneron Pharmaceuticals, Inc. | Miš z navadno lahko verigo |
| US9868786B2 (en) * | 2011-04-12 | 2018-01-16 | University Of Cincinnati | Methods for suppressing allergic reactions |
| WO2012169741A2 (ko) | 2011-06-07 | 2012-12-13 | (주)네오팜 | ＦｃεＲＩ 특이적 인간 항체 및 이를 포함하는 알레르기 질환 치료 또는 진단용 조성물 |
| JOP20200236A1 (ar) | 2012-09-21 | 2017-06-16 | Regeneron Pharma | الأجسام المضادة لمضاد cd3 وجزيئات ربط الأنتيجين ثنائية التحديد التي تربط cd3 وcd20 واستخداماتها |
| TWI682941B (zh) | 2013-02-01 | 2020-01-21 | 美商再生元醫藥公司 | 含嵌合恆定區之抗體 |
| EP2837637A1 (en) | 2013-08-16 | 2015-02-18 | SuppreMol GmbH | Novel anti-FcyRIIB IgG-type antibody |
| CN104293738A (zh) | 2013-09-11 | 2015-01-21 | 李莉 | 一种抗人FcεRⅠα亚基单克隆抗体及其应用 |
| EP2982693A1 (en) * | 2014-08-07 | 2016-02-10 | Affimed Therapeutics AG | CD3 binding domain |
| CA2957850A1 (en) | 2014-08-13 | 2016-02-18 | Suppremol Gmbh | Antibodies comprising binding domains to fc.epsilon. receptor (fc.epsilon.r) and fc gamma receptor iib (fc.gamma.riib) |
| CN104800164B (zh) | 2015-04-13 | 2017-11-07 | 上海市第一人民医院 | 一种雷公藤免疫纳米粒及用途 |
| LT3353212T (lt) | 2015-09-23 | 2021-12-27 | Regeneron Pharmaceuticals, Inc. | Optimizuoti anti-cd3 bispecifiniai antikūnai ir jų naudojimas |
| IL262241B2 (en) * | 2016-04-13 | 2024-05-01 | Sanofi Sa | Trispecific and/or trivalent binding proteins with a crossover dual variable domain arm and a traditional antibody fab arm, pharmaceutical composition comprising said binding proteins and their uses in preventing and/or treating cancer or inflammatory diseases |
| MY194596A (en) | 2016-09-23 | 2022-12-06 | Regeneron Pharma | Bi Specific Anti-Muc16-CD3 Antibodies And Anti-Muc16 Drug Conjugates |
| EP3840841A1 (en) | 2018-08-23 | 2021-06-30 | Regeneron Pharmaceuticals, Inc. | Anti-fc epsilon-r1 alpha (fcer1a) antibodies, bispecific antigen-binding molecules that bind fcer1a and cd3, and uses thereof |
-
2019
- 2019-08-22 EP EP19765582.2A patent/EP3840841A1/en active Pending
- 2019-08-22 JP JP2021510030A patent/JP7402223B2/ja active Active
- 2019-08-22 CA CA3109513A patent/CA3109513A1/en active Pending
- 2019-08-22 AU AU2019325565A patent/AU2019325565B2/en active Active
- 2019-08-22 BR BR112021003023-9A patent/BR112021003023A2/pt unknown
- 2019-08-22 CN CN201980069380.5A patent/CN112888482B/zh active Active
- 2019-08-22 WO PCT/US2019/047601 patent/WO2020041537A1/en not_active Ceased
- 2019-08-22 KR KR1020217008580A patent/KR20210049863A/ko active Pending
- 2019-08-22 IL IL280745A patent/IL280745B1/en unknown
- 2019-08-22 MY MYPI2021000853A patent/MY204368A/en unknown
- 2019-08-22 SG SG11202101608XA patent/SG11202101608XA/en unknown
- 2019-08-22 US US16/547,910 patent/US11578127B2/en active Active
- 2019-08-22 MX MX2021002165A patent/MX2021002165A/es unknown
- 2019-08-22 EA EA202190601A patent/EA202190601A1/ru unknown
-
2021
- 2021-02-10 ZA ZA2021/00919A patent/ZA202100919B/en unknown
- 2021-02-15 PH PH12021550322A patent/PH12021550322A1/en unknown
- 2021-02-19 CL CL2021000437A patent/CL2021000437A1/es unknown
- 2021-03-19 CO CONC2021/0003608A patent/CO2021003608A2/es unknown
-
2023
- 2023-01-12 US US18/153,522 patent/US12441797B2/en active Active
- 2023-02-13 CL CL2023000442A patent/CL2023000442A1/es unknown
- 2023-10-03 JP JP2023172194A patent/JP7541167B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7824339B2 (ja) | ヒトｉｌ－４受容体に対する高親和性ヒト抗体 | |
| RU2474588C2 (ru) | Перекрестно-реактивные антитела анти-il-17a/il-17f и способы их применения | |
| AU2014361473B2 (en) | PD-1 antibody, antigen-binding fragment thereof, and medical application thereof | |
| JP2017505125A5 (https=) | ||
| JP2020528768A (ja) | 抗ｔｉｇｉｔ抗体 | |
| CN112969719A (zh) | 双功能融合蛋白及其医药用途 | |
| CN115461368A (zh) | 抗人白细胞介素-4受体α抗体及其制备方法和应用 | |
| RU2012107286A (ru) | Высокоаффинные человеческие антитела к человеческому ангиопоэтину-2 | |
| RU2014148502A (ru) | Человеческие антитела к fel d1 и способы их применения | |
| CN115397852B (zh) | 工程化抗il-2抗体 | |
| JP2018510617A5 (https=) | ||
| CN106699891A (zh) | 一种抗pd‑l1 抗体、其药物组合物及其用途 | |
| JP2025067915A5 (https=) | ||
| JP2015503909A5 (https=) | ||
| JP2024024114A5 (https=) | ||
| JP2022516351A (ja) | 抗ｔｉｇｉｔ抗体 | |
| CN116323666A (zh) | Fgfr3抗体和使用方法 | |
| JP2021533806A5 (https=) | ||
| JP2023538117A (ja) | 神経免疫疾患のためのｃｄ３／ｃｄ２５抗体 | |
| JP2019537449A (ja) | 抗ｇｉｔｒ抗原結合タンパク質およびその使用方法 | |
| JP2019528046A5 (https=) | ||
| JP2022525937A (ja) | Ｂｔｎ２に対する特異性を有する抗体及びその使用 | |
| CN112480252B (zh) | 抗白细胞介素-33抗体及其制备方法和应用 | |
| JPWO2020041537A5 (https=) | ||
| JPWO2021007533A5 (https=) |